Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8846538rdf:typepubmed:Citationlld:pubmed
pubmed-article:8846538lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:8846538lifeskim:mentionsumls-concept:C0014653lld:lifeskim
pubmed-article:8846538lifeskim:mentionsumls-concept:C0003209lld:lifeskim
pubmed-article:8846538lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:8846538pubmed:dateCreated1996-10-23lld:pubmed
pubmed-article:8846538pubmed:abstractTextHigh levels of proinflammatory cytokines such as IL-1, TNF-alpha and IL-6 are produced by the rheumatoid synovitis. These cytokines, mainly produced by monocytes/macrophages, are thought to play a major role in chronic inflammation and in the final joint degradation. IL-4, IL-10, and IL-13 have been classified as antiinflammatory cytokines as they inhibit the production of the proinflammatory cytokines by monocytes. Acting on the balance between these two groups of cytokines may lead to new therapeutic approaches to controlling chronic inflammation without interfering at the level of the antigen.lld:pubmed
pubmed-article:8846538pubmed:languageenglld:pubmed
pubmed-article:8846538pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8846538pubmed:citationSubsetIMlld:pubmed
pubmed-article:8846538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8846538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8846538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8846538pubmed:statusMEDLINElld:pubmed
pubmed-article:8846538pubmed:issn0392-856Xlld:pubmed
pubmed-article:8846538pubmed:authorpubmed-author:MiossecPPlld:pubmed
pubmed-article:8846538pubmed:issnTypePrintlld:pubmed
pubmed-article:8846538pubmed:volume13 Suppl 12lld:pubmed
pubmed-article:8846538pubmed:ownerNLMlld:pubmed
pubmed-article:8846538pubmed:authorsCompleteYlld:pubmed
pubmed-article:8846538pubmed:paginationS13-6lld:pubmed
pubmed-article:8846538pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:8846538pubmed:meshHeadingpubmed-meshheading:8846538-...lld:pubmed
pubmed-article:8846538pubmed:meshHeadingpubmed-meshheading:8846538-...lld:pubmed
pubmed-article:8846538pubmed:meshHeadingpubmed-meshheading:8846538-...lld:pubmed
pubmed-article:8846538pubmed:meshHeadingpubmed-meshheading:8846538-...lld:pubmed
pubmed-article:8846538pubmed:meshHeadingpubmed-meshheading:8846538-...lld:pubmed
pubmed-article:8846538pubmed:meshHeadingpubmed-meshheading:8846538-...lld:pubmed
pubmed-article:8846538pubmed:meshHeadingpubmed-meshheading:8846538-...lld:pubmed
pubmed-article:8846538pubmed:articleTitlePro- and antiinflammatory cytokine balance in rheumatoid arthritis.lld:pubmed
pubmed-article:8846538pubmed:affiliationDepartment of Immunology, Hôpital Edouard Herriot, Lyon, France.lld:pubmed
pubmed-article:8846538pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8846538pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8846538lld:pubmed